Managing cancer screening anxiety in Fanconi anemia
Part of Blood & lymphatic, Cancer, Genetic & congenital, Hormones & metabolism clinical trials.
This study observes and talks with adults with Fanconi anemia about their feelings during cancer screening visits. It aims to learn how to better support people with FA through screening anxiety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Fanconi anemia.
- You are already enrolled in the FACSS study at the NIH Clinical Center.
- You can speak, read, and write in English to give verbal consent.
- You agree to let your de-identified data be used for future research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
This study screens people who may have an inherited risk for certain cancers due to their personal or family medical history or known gene changes. By completing a survey, you can help researchers find the right study for you and learn more about your cancer risk.
This study uses MRI (a safe imaging scan) to detect and track dangerous changes in the mouth of people with Fanconi Anemia, a rare genetic condition. The goal is to find a better way to catch oral cancer early.
This trial tests giving a stem cell transplant to a fetus with Fanconi anemia before birth, using the mother's bone marrow cells. The goal is to help the baby's body make healthy blood cells before symptoms start.
This Phase 2 study tests a stem cell transplant approach using adjusted chemotherapy doses for people with Fanconi anemia. It may help replace damaged bone marrow and treat blood problems like severe aplastic anemia, MDS, or leukemia.
This study asks adults aged 65 and older about their views on geriatric and functional assessments to help plan cancer treatment. It tests whether these assessments are acceptable and useful to patients.
Hear when a new Fanconi Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.